| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/09/2005 | CA2799245A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 09/09/2005 | CA2599304A1 Cell targeting conjugates |
| 09/09/2005 | CA2575416A1 Bone sialoprotein collagen-binding peptides |
| 09/09/2005 | CA2559415A1 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
| 09/09/2005 | CA2558178A1 Recombinant perforin, expression and uses thereof |
| 09/09/2005 | CA2558155A1 Casein derived peptides and therapeutic uses thereof |
| 09/09/2005 | CA2557597A1 A novel cofactor that modulates steroid receptor activities |
| 09/09/2005 | CA2557503A1 Methods for diagnosing and treating bladder cancer |
| 09/09/2005 | CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha. |
| 09/09/2005 | CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 09/09/2005 | CA2557151A1 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity |
| 09/09/2005 | CA2557136A1 Flavivirus vaccines |
| 09/09/2005 | CA2556893A1 Antihypertensive peptides |
| 09/09/2005 | CA2556632A1 Egf receptor epitope peptides and uses thereof |
| 09/09/2005 | CA2556479A1 Methods and compositions comprising supramolecular constructs |
| 09/09/2005 | CA2556104A1 Diagnosis or treatment of endothelial cell dysfunction related diseases |
| 09/09/2005 | CA2556022A1 Protein phosphorylation in t-cell receptor signaling pathways |
| 09/09/2005 | CA2556021A1 Protein phosphorylation in anaplastic large cell lymphoma |
| 09/09/2005 | CA2556019A1 Protein phosphorylation in c-src signaling pathways |
| 09/09/2005 | CA2555583A1 Positive modulator of bone morphogenic protein-2 |
| 09/09/2005 | CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 09/09/2005 | CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use |
| 09/09/2005 | CA2554238A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells |
| 09/09/2005 | CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure |
| 09/09/2005 | CA2552346A1 Membrane scaffold proteins |
| 09/09/2005 | CA2548220A1 Use of mda-7 to inhibit infection by pathogenic organisms |
| 09/09/2005 | CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis |
| 09/08/2005 | US20050198712 Glutamine-rich maize seed protein and promoter |
| 09/08/2005 | US20050198710 Method of improving soybean protein color by reducing levels of flavonol |
| 09/08/2005 | US20050198707 Expression vector comprisig nucleotide sequences coding arsenate reductase for use in detoxification of metal ions in soil; bioremediation |
| 09/08/2005 | US20050198702 Expression vector comprising tissue specific regulatory sequences for generating transgenic plants with enhanced phytohormone, carbohydrate and fatty acid metabolism and/or biosynthesis |
| 09/08/2005 | US20050198701 Using recombinant zebrafish to propagating ornamental progeny in hatcheries; animal husbandry |
| 09/08/2005 | US20050198698 Transgenic cattle for use as bioreactor for heterologus gene expression |
| 09/08/2005 | US20050198697 Transgenic mollusk and method for producing the same |
| 09/08/2005 | US20050198696 Animal model for lymphocyte development; treating blood, cell proliferative and kidney disorders |
| 09/08/2005 | US20050198695 Nematode ATP synthase subunit E-like sequences |
| 09/08/2005 | US20050198694 Truncated fragments of alpha-synuclein in Lewy body disease |
| 09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
| 09/08/2005 | US20050197495 purification of transferrins using surfactants, antioxidants and flavonoids, than drying the pure glycoproteins |
| 09/08/2005 | US20050197493 Fibrinogen purification |
| 09/08/2005 | US20050197492 Crystal structure of VEGFRKD: ligand complexes and methods of use thereof |
| 09/08/2005 | US20050197491 Comprises brain glycoprotein for use in identifying modulators which can be used in diagnosis and treatment of nervous system disorders |
| 09/08/2005 | US20050197318 Acidic oligosaccharide fragments produced by marine sponges and sea urchin embryos; potent stimulators of natural killer cells and gamma delta T cells; cancer, viral infections |
| 09/08/2005 | US20050197311 Vector comprising first polynucleotide encoding glucose responsive mRNA instability element, second polynucleotide encoding reporter polypeptide and promoter sequence; fluorescence based high throughput screening |
| 09/08/2005 | US20050197310 TGaseII polypeptide antibodies; pulmonary, kidney, liver or ocular fibrosis; cardiac hypertrophy, atherosclerosis, restenosis; Alzheimer's and Parkinson's disease |
| 09/08/2005 | US20050197308 drug delivery devices having skin piercing segments comprising solid biodegradable reservoirs containing antigens |
| 09/08/2005 | US20050197307 Antagonizing interaction between polynucleotide sequence 1 and interferon regulatory factor 1 (IRF 1); herpes virus infections |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | US20050197298 Water soluble, prevention of neovascularization |
| 09/08/2005 | US20050197297 Method for increasing the serum half-life of a biologically active molecule |
| 09/08/2005 | US20050197295 Modified annexin proteins and methods for preventing thrombosis |
| 09/08/2005 | US20050197293 Use of an IL-1 antagonist for treating arthritis |
| 09/08/2005 | US20050197292 Inhibiting the release of cytokines from immune cells by contacting the cells with a composition comprising a CG57008 polypeptide; for preventing and/or treating inflammatory and autoimmune diseases; asthma, allergy, atopic eczema, inflammatory bowel disease, systemic lupus erythematosus, arthritis |
| 09/08/2005 | US20050197285 Human secreted proteins |
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196861 Physiologically active peptides |
| 09/08/2005 | US20050196860 Novel EPS8 compounds for therapy and diagnosis and methods for using same |
| 09/08/2005 | US20050196858 Isolation, selection and propagation of animal transgenic stem cells |
| 09/08/2005 | US20050196847 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 09/08/2005 | US20050196846 Transgenic coryneform for use as bioreactor in fermentation of glutamic acid for use in medicine, foods and animal feeds |
| 09/08/2005 | US20050196842 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 09/08/2005 | US20050196840 Glucose transport proteins for use in identifying modulators which prevent glucose uptake; diabetes diagnostic and therapeutic |
| 09/08/2005 | US20050196832 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/08/2005 | US20050196831 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 09/08/2005 | US20050196830 Amino acid modified polypeptides |
| 09/08/2005 | US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders |
| 09/08/2005 | US20050196814 Human suppressor of fused |
| 09/08/2005 | US20050196810 Providing a library of peptides comprising a trpzip scaffold, contacting the library with the bioactive target molecule; selecting at least one peptide capable of forming a noncovalent complex with the bioactive target molecule from the library; isolating peptide |
| 09/08/2005 | US20050196808 Products and processes for modulating peptide-peptide binding domain interactions |
| 09/08/2005 | US20050196807 Gene mining system and method |
| 09/08/2005 | US20050196806 Prostate specific antigen oligoepitope peptide |
| 09/08/2005 | US20050196805 Oligonucleotide primers for use as diagnostic tool in detection of plant bacterial pathogen of plants |
| 09/08/2005 | US20050196801 Screening assays for agonists or antagonists or receptor activator of NF-kappaB |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196795 Using macrophage migration inhibitory factor (MIF) concentration as diagnostic/prognostic tool in detection and prevention of cell proliferative disorders of urogenital systems; antitumor agents |
| 09/08/2005 | US20050196791 Probe for mass spectrometry |
| 09/08/2005 | US20050196783 Nucleotide sequences coding r-ounidabout (robo) regulatory protein (SLIT polypeptides) for use in treatment and prevention of nervous system disorders; nerve cell function modulators |
| 09/08/2005 | US20050196774 Modified nucleotide sequences with enhanced geneic expression in heterologous host cells |
| 09/08/2005 | US20050196772 Nucleotide sequences coding lysosomal membrane glycoprotein for use as tool in prevention and treatment of bone disorders |
| 09/08/2005 | US20050196768 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 09/08/2005 | US20050196759 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 09/08/2005 | US20050196757 Orphan receptor for idenifying modulators for treatment and prevention cell proliferative disorders; immunodiagnostics |
| 09/08/2005 | US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy |
| 09/08/2005 | US20050196752 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 09/08/2005 | US20050196751 Receptor protein is capable of activating transcription of desired gene when in presence of agonist and when bound to antagonist; gene therapy; gene expression inhibition; transgenic cells, animals |
| 09/08/2005 | US20050196427 Engineered proteins, and methods of making and using |
| 09/08/2005 | US20050196425 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation |
| 09/08/2005 | US20050196414 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treat wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne |
| 09/08/2005 | US20050196412 Vaccine; components, parts, fragments and derivatives, genetic sequences; development of diagnostic and therapeutic compositions for treatment and prophylaxis of AIDS and related disorders; attenuating pathogenic strains of HIV-1 by mutagenizing particular regions of the HIV-1 genome; low risk |
| 09/08/2005 | US20050196408 Stimulating an immune response in a primate utilizing bacterial adhesin proteins and/or imunogenic fragments |
| 09/08/2005 | US20050196407 Isolated polypeptide comprising a claimed amino acid sequence |
| 09/08/2005 | US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand |
| 09/08/2005 | US20050196405 Pneumococcal surface protein c (pspc), epitopic regions and strain selection thereof, and uses therefor |
| 09/08/2005 | US20050196404 Gene is introducted into porcine cells folds properly and confers protection against human NK cell-mediated killing; polynucleotide, vector, antibody and the anti-idiotypic antibody |
| 09/08/2005 | US20050196403 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 09/08/2005 | US20050196402 Immunoglobulin constant region modified to reduce mediated biological effector function relative to a CTLA4-IgG1 fusion protein; nucleic acids integrated into expression vectors direct synthesis of corresponding proteins in a variety of hosts; inhibit transplantation rejection, graft versus host disease |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196398 Nucleotide sequences coding specialized hydrolase for use as tool in identifying modulator for prevention and treatment of nervous system disorders; enzyme inhibitors |
| 09/08/2005 | US20050196393 Add trisodium citrate to get cryoprecipitate without freezing plasma, without chromatography; single donors, limited pools; cryoprecipitate formed into a fibrin fabric; surgeries, wounds |
| 09/08/2005 | US20050196390 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |